Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.

Using various mutants of p53 and mdm2, we demonstrate here that both the DNA binding and transactivation function of p53 are required for ASPP1 and ASPP2 to stimulate the apoptotic functions of p53. Mdm2 and mdmx prevent ASPP1 and ASPP2 from stimulating the apoptotic function of p53 by binding and i...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Bergamaschi, D, Samuels, Y, Zhong, S, Lu, X
Formatua: Journal article
Hizkuntza:English
Argitaratua: 2005
_version_ 1826291122662539264
author Bergamaschi, D
Samuels, Y
Zhong, S
Lu, X
author_facet Bergamaschi, D
Samuels, Y
Zhong, S
Lu, X
author_sort Bergamaschi, D
collection OXFORD
description Using various mutants of p53 and mdm2, we demonstrate here that both the DNA binding and transactivation function of p53 are required for ASPP1 and ASPP2 to stimulate the apoptotic functions of p53. Mdm2 and mdmx prevent ASPP1 and ASPP2 from stimulating the apoptotic function of p53 by binding and inhibiting the transcriptional activity of p53. Importantly, mdm2 and mdmx can prevent the stimulatory effects of ASPP1 and ASPP2 without targeting p53 for degradation. These data provide a novel mechanism by which mdm2 and mdmx act as potent inhibitors of p53.
first_indexed 2024-03-07T02:54:39Z
format Journal article
id oxford-uuid:aedbe8b0-bec8-4d4e-a169-95990082a6b6
institution University of Oxford
language English
last_indexed 2024-03-07T02:54:39Z
publishDate 2005
record_format dspace
spelling oxford-uuid:aedbe8b0-bec8-4d4e-a169-95990082a6b62022-03-27T03:45:37ZMdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:aedbe8b0-bec8-4d4e-a169-95990082a6b6EnglishSymplectic Elements at Oxford2005Bergamaschi, DSamuels, YZhong, SLu, XUsing various mutants of p53 and mdm2, we demonstrate here that both the DNA binding and transactivation function of p53 are required for ASPP1 and ASPP2 to stimulate the apoptotic functions of p53. Mdm2 and mdmx prevent ASPP1 and ASPP2 from stimulating the apoptotic function of p53 by binding and inhibiting the transcriptional activity of p53. Importantly, mdm2 and mdmx can prevent the stimulatory effects of ASPP1 and ASPP2 without targeting p53 for degradation. These data provide a novel mechanism by which mdm2 and mdmx act as potent inhibitors of p53.
spellingShingle Bergamaschi, D
Samuels, Y
Zhong, S
Lu, X
Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
title Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
title_full Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
title_fullStr Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
title_full_unstemmed Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
title_short Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
title_sort mdm2 and mdmx prevent aspp1 and aspp2 from stimulating p53 without targeting p53 for degradation
work_keys_str_mv AT bergamaschid mdm2andmdmxpreventaspp1andaspp2fromstimulatingp53withouttargetingp53fordegradation
AT samuelsy mdm2andmdmxpreventaspp1andaspp2fromstimulatingp53withouttargetingp53fordegradation
AT zhongs mdm2andmdmxpreventaspp1andaspp2fromstimulatingp53withouttargetingp53fordegradation
AT lux mdm2andmdmxpreventaspp1andaspp2fromstimulatingp53withouttargetingp53fordegradation